Orthostatic hypotension (OH) is a common cardiovascular disorder, with or without signs of underlying neurodegenerative disease. OH is diagnosed on the basis of an orthostatic challenge and implies a persistent systolic/diastolic blood pressure decrease of at least 20/10 mm Hg upon standing. Its prevalence is age dependent, ranging from 5% in patients <50 years of age to 30% in those >70 years of age. OH may complicate treatment of hypertension, heart failure, and coronary heart disease; cause disabling symptoms, faints, and traumatic injuries; and substantially reduce quality of life. Despite being largely asymptomatic or with minimal symptoms, the presence of OH independently increases mortality and the incidence of myocardial infarction, stroke, heart failure, and atrial fibrillation. In this review, we outline the etiology and prevalence of OH in the general population, summarize its relationship with morbidity and mortality, propose a diagnostic and therapeutic algorithm, and delineate current challenges and future perspectives. 
O rthostatic hypotension (OH) is a key manifestation of autonomic dysfunction, typically observed when cardiovascular adaptive mechanisms fail to compensate for the reduction in venous return that normally occurs on assuming the upright position. It reflects a structural or functional sympathetic denervation or a deranged reflex regulation of sympathetic outflow (1) . OH is the second most common etiology of syncope, occurring in approximately 15% of syncope presentations (2) . It frequently affects older people and patients who have neurodegenerative disease, diabetes, or hypertension. Unfortunately, OH is often unrecognized or misdiagnosed and may be an overlooked factor associated with increased cardiovascular morbidity and all-cause mortality. Its management includes both pharmacological and nonpharmacological measures that are not always satisfactory and may lead to complications (3) . In this review, we first outline the pathophysiology of OH; discuss its etiology, epidemiology, and prognosis; and propose a diagnostic and therapeutic algorithm.
THE HOMEOSTATIC REGULATION OF BLOOD PRESSURE
Cardiovascular blood pressure (BP) homeostasis refers to compensatory adjustments aimed at buffering changes in BP and opposing cardiovascular remodeling. Regulation of BP is a very complex physiological function that depends on a continuum of actions of the cardiovascular, neural, renal, and endocrine systems (4) . In contrast to the local (peripheral) regulation of tissue BP, which primarily aims to achieve a tight matching of regional blood flow to local metabolic demands and occurs through locally produced mediators (autacoids), including eicosanoids, nitric oxide, endothelins, and tissue plasminogen activator, the central circulation maintains tight control of BP through changes in cardiac output and vascular tone. Central regulatory mechanisms control the sympathetic outflow to the cardiovascular system in both the short and long term (5). Short-term reflex control of the sympathetic vasomotor activity is regulated by homeostatic feedback mechanisms, such as the baroreceptor and chemoreceptor reflexes. Central mechanisms also produce specific patterns of sympathetic activity according to different external stimuli or stresses (6, 7) . In the long term, cardiovascular homeostasis depends on a more complex interplay of several mechanisms, including changes in the sympathetic vasomotor outflow, renal control of extracellular volume, pressure natriuresis, and the activity of antagonistic "push-pull" systems (8) , such as the kallikrein-kinin and renin-angiotensinaldosterone systems (5, 6, (9) (10) (11) (12) .
PHYSIOLOGY OF UPRIGHT POSTURE. Orthostatic stress is a common daily challenge for humans when posture changes from lying to standing or during prolonged quiet standing. Almost immediately, with the transition from the supine (recumbent) to the upright (erect) position, a gravitational shift of nearly 500 ml of blood away from the chest to the distensible venous capacitance system below the diaphragm (venous pooling) occurs. This results in a rapid decrease in central blood volume and a subsequent reduction of ventricular preload, stroke volume, and mean BP (13) .
In the vascular system, a reference quantitative determinant of these changes is the venous hydrostatic indifference point (HIP), when pressure is independent of posture (14) . In humans, the venous HIP is approximately at the diaphragmatic level, whereas the arterial HIP lies close to the level of the left ventricle (14) . The venous HIP is dynamic and is significantly affected by venous compliance and muscular activity.
Upon standing, contractions of lower limb muscles, along with the presence of venous valves, provide an intermittent unidirectional flow, moving the venous HIP toward the right atrium (15) . Respiration may also increase venous return because deep inspiration results in both a decline in thoracic pressure and an increase in intraabdominal pressure, which lowers retrograde flow due to compression of both the iliac and femoral veins (14) . To provide an appropriate perfusion pressure to critical organs, an effective set of the neural regulatory system is promptly activated upon standing (6) . The sympathetic nervous system is fast anisms within seconds, resulting in increased heart rate, myocardial contractility, and peripheral vasoconstriction (17) . An additional local axon reflex, the veno-arteriolar axon reflex, results in constriction of arterial flow to the muscles, skin, and adipose tissue, leading to almost one-half of the increase in vascular resistance in the limbs upon standing (14, 18, 19) . (23, 24) . Both reflex syncope and postural orthostatic tachycardia syndrome have been discussed in detail elsewhere (22, (25) (26) (27) .
OH can be classified as either primary or secondary In many cases when the structural autonomic disease cannot be confirmed, the term idiopathic OH has been widely used (29) . Recent data indicate that autoimmune activity against adrenergic and musca- OH has been traditionally associated with neurodegenerative diseases (1), frailty in elderly patients (35) , and chronic heart failure (36), but it is also a frequent finding among patients with hypertension (37, 38) and patients with diabetes (39) . In published reports, its prevalence ranges between 6% and 35% or more, depending on age and associated comorbidities, showing a strong association with elevated BP (37, 38, 40, 41) . In many chronic conditions, such as renal failure or autoimmune diseases, OH has a higher prevalence than in the general population, suggesting the multifactorial etiology of autonomic failure.
There is now growing evidence that disorders of postural hemodynamic control predict all-cause mortality (42-44) and incidence of cardiovascular disease (44, 45) , being prognostically more relevant than the ambulatory BP monitoring-derived nighttime reverse dipping (46) . According to the available longitudinal data, OH is associated with increased risk of major adverse cerebrocardiovascular events, although results have not always been consistent (43, 47, 48) . Nonetheless, a recent meta-analysis of prospective observational studies confirmed that the presence of OH was independently associated with increased risk of all-cause death, incident coronary heart disease, heart failure, and stroke (49) . Unexpectedly, post-hoc subgroup analysis documented a stronger association between OH and mortality in the population <65 years of age, whereas such association barely attained full statistical significance in the older subgroup (49) . Similar discrepancies were also observed in the ARIC (Atherosclerosis Risk in Communities) study (50, 51) (54) is known to be associated with the occurrence of atrial fibrillation (55, 56) , which is itself a well-known risk factor for heart failure (57) and cardioembolic stroke (58). Fedorowski et al. (59) observed that, independent of conventional risk factors, the long-term incidence of atrial fibrillation was 
FIGURE 4 Proposed Algorithm for the Diagnosis and Management of OH
When should we suspect orthostatic hypotension?
• Unexplained syncope/fall
• Typical symptoms (dizziness, lightheadedness, chronic fatigue, confusion, gait disorders, neck pain, vision disturbance)
• Patient's history (age, neurodegenerative disease, diabetes, renal failure, amyloidosis, heart disease, hypertension, autoimmune disease)
• Current pharmacological treatment (vasodilators, diuretics, alpha-and beta-blockers, tricyclic antidepressants)
Initial assessment (ED, hospital, and outpatient clinic)
• Physical examination
• Laboratory assessment (Hb, electrolytes, glucose, creatinine, TSH)
• Bedside BP supine/standing test (after 1-3-5 min)
• Cardiac assessment (ECG, telemetry or Holter-ECG, echocardiography, exercise-ECG, angiography if indicated, i.e., history or signs of cardiac disease)
• Neurological assessment (neurological status, and brain imaging if indicated, i.e., history of head trauma and/or neurological symptoms)
Please see Central Illustration for grading of symptoms and Table 1 for therapeutic options.
+ OH confirmed
Pharmacological/compression therapy (Class III-IV)
Nonpharmacological methods + drug modification (Class I-II)
Advanced cardiac and autonomic assessment (investigation unit led by experts)
• Head-up tilt test with continuous BP monitoring plus active standing test, carotid sinus massage, and Valsalva test (if positive, indicative of neurogenic OH); neuroendocrine assessment (supine and standing epinephrine/norepinephrine; other biomarkers such as renin, endothelin-1, vasopressin, natriuretic peptides can be considered)
• 24-h-ambulatory BP monitoring (BP variability pattern? Nondipping? Reversed dipping? Diurnal hypotension periods? Overtreatment? White-coat syndrome?)
• Long-term ECG monitoring if indicated (Cardiac arrhythmia? Chronotropic insufficiency?)
• Cardiac sympathetic neuroimaging (PET or MIBG, optional, if available)
Specialist consultation/referrals (if indicated)
• Cardiologist (OH with concurrent cardiac arrhythmia, structural heart disease, and/or severe hypertension)
• Neurologist (neurogenic OH and/or concurrent neurodegenerative disease such as Parkinson's disease, pure autonomic failure, or multiple system atrophy)
• Geriatrician (older patient with special needs and comorbidities, fall tendency, cognitive impairment, dementia)
• Endocrinologist (patients with suspected or confirmed endocrine disorders such as electrolyte abnormalities, hypothyroidism, or adrenal diseases)
• Otolaryngologist ("dizziness" with preserved normal hemodynamic parameters or typical vertigo) ECG ¼ electrocardiography; ED ¼ emergency department; Hb ¼ hemoglobin; MIBG ¼ meta-iodobenzylguanidine; OH ¼ orthostatic hypotension; PET ¼ positron emission tomography; TSH ¼ thyroid-stimulating hormone; other abbreviations as in Figure 3 .
effects exerted by compression garments are immediate and easily recognized by the patient, and the method can be applied only when needed (i.e., when a prolonged orthostatic challenge is expected or planned). Four classes of patients with orthostatic hypotension (OH) according to symptom severity. The prevalence of OH is progressively lower with increasing symptoms. The overall prevalence of orthostatic hypotension in the middle-aged population is estimated to be 6% to 10%, but may rise higher than 20% in those >75 years of age. The proportion of patients with class III to IV (i.e., with pronounced symptoms of orthostatic intolerance) is approximately 1:10 in the overall population of patients with OH. Pharmacological treatment is necessary in class IV, is recommended in class III, can be considered in class II, and is generally not recommended in class I patients (see also Figure 4 or localized edema, including pulmonary edema and ascites, as well as aggravated hypertension and hypokalemia. Thus, the use of fludrocortisone in patients with heart failure, kidney failure, or hypertension is contraindicated.
Another important aspect of pharmacological therapy in OH is related to cardiovascular comorbidities. Because several drugs used for treatment of ischemic heart disease, heart failure, cardiac arrhythmias, and hypertension may have a negative impact on postural homeostasis, tailored therapy is needed to avoid worsening of orthostatic symptoms ( Table 1) . In general, 24-h ambulatory BP monitoring should be performed first, and nighttime administration of short-acting antihypertensive drugs is preferred, even if the patient is treated for ischemic heart disease or heart failure. Drug classes to be avoided are presented in Table 1 .
In choosing a specific drug, a peak effect time 
